Efficacy Optimizing Research of Lamivudine Therapy
Phase 4
Completed
- Conditions
- Compensated Chronic Hepatitis B
- Interventions
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 366
- Registration Number
- NCT01088009
- Locations
- 🇨🇳
First Affiliated Hospital of Guangxi Medical University, NanNing, Guangxi, China
🇨🇳Xiangya Hospital Central-South Univrsity, ChangSha, Hunan, China
🇨🇳HangZhou No.6 People Hospital, Hangzhou, Zhejiang, China
EFFicacy Optimization Research of Telbivudine Therapy
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2013-01-31
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 606
- Registration Number
- NCT00962533
- Locations
- 🇨🇳
West China Hospital.SiChuan University, ChengDu, Sichuan, China
🇨🇳Changhai Hospital affiliated to Second Military Medical University, ShangHai, Shanghai, China
🇨🇳302 Military Hospital of China, BeiJing, Beijing, China
Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
Not Applicable
Terminated
- Conditions
- Renal Insufficiency, Chronic
- Interventions
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 309
- Registration Number
- NCT00630708
- Locations
- 🇨🇳
Renal Division, Nanfang Hospital,Southern Medical University, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath